Literature DB >> 12823170

Personality and self-variables: important determinants of subjective quality of life in schizophrenia out-patients.

M Eklund1, M Bäckström, L Hansson.   

Abstract

OBJECTIVE: To investigate factors determining severely mentally ill patients' self-rated quality of life. The study hypothesized that objective life circumstances, personality, self-variables, and psychopathology would be determinants of quality of life.
METHOD: A total of 117 individuals with schizophrenia and related disorders were investigated. Structural equation modelling was used to: 1). investigate if one or more subfactors best described the covariance within each potential determinant and quality of life, 2). explore the relations between all variables and factors extracted in step 1.
RESULTS: A multi-factorial model indicated that a self-factor and two psychopathology factors worked as mediators of self-rated quality of life, in turn composed of an internal and an external aspect. Personality dimensions and objective life circumstances accounted directly or indirectly for substantial parts of quality of life.
CONCLUSION: The relative importance of individual characteristics and objective indices was shown. Trait-like properties, such as the self-factor and personality, explained most of the variation in self-rated quality of life.

Entities:  

Mesh:

Year:  2003        PMID: 12823170     DOI: 10.1034/j.1600-0447.2003.00103.x

Source DB:  PubMed          Journal:  Acta Psychiatr Scand        ISSN: 0001-690X            Impact factor:   6.392


  16 in total

1.  Ten-year quality of life outcomes among patients with schizophrenia and schizoaffective disorder II. Predictive value of psychosocial factors.

Authors:  Michael S Ritsner; Marina Arbitman; Alexander Lisker; Alexander M Ponizovsky
Journal:  Qual Life Res       Date:  2011-10-02       Impact factor: 4.147

2.  Daily activities mediate the relationship between personality and quality of life in middle-aged women.

Authors:  Mona Eklund; Martin Bäckström; Lauren Lissner; Cecilia Björkelund; Ulla Sonn
Journal:  Qual Life Res       Date:  2010-07-17       Impact factor: 4.147

3.  Validity of an abbreviated quality of life enjoyment and satisfaction questionnaire (Q-LES-Q-18) for schizophrenia, schizoaffective, and mood disorder patients.

Authors:  Michael Ritsner; Rena Kurs; Anatoly Gibel; Yael Ratner; Jean Endicott
Journal:  Qual Life Res       Date:  2005-09       Impact factor: 4.147

4.  Quality of life and temperament factors in schizophrenia: comparative study of patients, their siblings and controls.

Authors:  Rena Kurs; Herman Farkas; Michael Ritsner
Journal:  Qual Life Res       Date:  2005-03       Impact factor: 4.147

5.  Determinants of changes in perceived quality of life in the course of schizophrenia.

Authors:  Michael Ritsner; Anatoly Gibel; Yael Ratner
Journal:  Qual Life Res       Date:  2006-04       Impact factor: 4.147

Review 6.  Determinants of functioning and well-being among individuals with schizophrenia: an integrated model.

Authors:  P T Yanos; R H Moos
Journal:  Clin Psychol Rev       Date:  2006-02-09

7.  A model of subjective quality of life for outpatients with schizophrenia and other psychoses.

Authors:  Mona Eklund; Martin Bäckström
Journal:  Qual Life Res       Date:  2005-05       Impact factor: 4.147

8.  Quality of Life Among People with Psychiatric Disabilities: Does Day Centre Attendance Make a Difference?

Authors:  Argentzell Elisabeth; Tjörnstrand Carina; Eklund Mona
Journal:  Community Ment Health J       Date:  2017-01-19

9.  Personality compensates for impaired quality of life and social functioning in patients with psychotic disorders who experienced traumatic events.

Authors:  Lindy-Lou Boyette; Daniëlla van Dam; Carin Meijer; Eva Velthorst; Wiepke Cahn; Lieuwe de Haan; René Kahn; Lieuwe de Haan; Jim van Os; Durk Wiersma; Richard Bruggeman; Wiepke Cahn; Carin Meijer; Inez Myin-Germeys
Journal:  Schizophr Bull       Date:  2014-04-25       Impact factor: 9.306

Review 10.  Current issues in schizophrenia: overview of patient acceptability, functioning capacity and quality of life.

Authors:  Martin Lambert; Dieter Naber
Journal:  CNS Drugs       Date:  2004       Impact factor: 5.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.